🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Fantastic presentation by PhD student Niall Ashfield on drug resistance in cancer for The Tell it Straight 2024 competition in Dublin City University DCU Research DCU School of Biotechnology DCU Science and Health CCRT ProfJohnCrown Amira Mahdi

Well done Niall!! Would have loved to see you in action 😁

📣New preprint out now! 🔬 We found that neratinib and dasatinib were highly synergistic in models of HER2-positive breast cancer in vitro and in vivo and can overcome neratinib resistance. ssrn.com/abstract=47440… Denis Collins ProfJohnCrown DCU School of Biotechnology

Fantastic presentation by PhD student Marta Valenti, PhD in Skopje, North Macedonia today at the immunomodel workshop highlighting her @scienceirl funded research! DCU Research DCU School of Biotechnology DCU Science and Health DCU Science & Health Comm DCU Biodesign Europe

Denis Collins and his team DCU Life Sciences Institute have discovered a chemotherapy drug that works in drug resistant skin cancer cells #Cancer #Chemotherapy DCU Research dcu.ie/science-and-he…

Great work by DCU cancer researchers presented at #AACR2024! @scienceirel CCRT HealthResearchBoard DCU Research DCU School of Biotechnology DCU Science and Health ProfJohnCrown @PumaBiotech DCU Biodesign Europe DCU Life Sciences Institute

🌸🎗️The Lancet Breast Cancer Commission have put together a powerful road map addressing prevention, personalized treatment, collaboration, and patient empowerment. Highly recommended reading for clinicians and patients alike. #bcsm #MedEd ow.ly/P5Hi50RjO4I

In pts w/ HR+ mBC (with HER2low, or HER2 ultralow dz) TDXd led to a significant ⬆️ in PFS c/w TPC Press release out from DESTINY-Breast06 Will be very interested to see the data; will have profound impact on tx sequencing + could put an end to HER2low as a biomarker

38 years ago a woman in Coventry sent a letter to some scientists. That letter went on to be the most important in Alzheimer's research. Last year, I met Carol Jennings, who wrote it. 1/ thetimes.co.uk/article/e78c47…

Looking forward to meeting Amira Mahdi Dr Amira Mahdi University of Limerick &presenting her work on Novel endocrine therapies for the treatment of breast cancer: a focus on HER2+/ER+ combination May 15th All welcome!! Details below:

The HRI has three PhD vacancies for the right candidates. One in the of Ageing, Stroke Rehabilitation and Health Services Research. One in Breast Cancer Research and the third related to Sláintecare Healthy Communities Programme. Email [email protected] for a description of each.

The University of Limerick, School of Medicine would like to wish the best of luck to recent BMBS UL Medical Graduate, Jeremy Bagshaw, class of 2024, who is making his Olympic debut today swimming in the Canadian quartet for the 4x200m Freestyle relay. #StudyatUL #Paris2024

Our new paper in Translational Oncology! 🧬 Thrilled to announce publication of "Neratinib plus dasatinib is highly synergistic in HER2+ breast cancer in vitro and in vivo." Thanks to all co-authors & CCRT We are now Research Ireland @PumaBiotech for support sciencedirect.com/science/articl…

Thirty incredible speakers for #TransOncXVII Herbert Park Hotel & Park Residence September 25-27. including Denis Slamon-Tak Mak-Eileen O Reilly-Patrick Forde-Mark Pegram-Lajos Pusztai-John Haanen-Josh LaBaer-Robert Kerbel. Registration free ! eventbrite.ie/e/the-17th-int…

Special notice!!! Prof Hurvitz is a world leader in breast cancer care and research. The meeting is free and open to the public. Of interest to patients, carers, and the general public.

October is #BreastCancerAwarenessMonth, and we're spotlighting our Breast Services team at UHL. Meet some of the dedicated professionals who support our patients. Learn more about our services➡️ bit.ly/3ZVzFZp #OurPeopleOurServices #TeamHSEMidWest

I'm so excited to be representing DCU in the National 'Three Minute Thesis' final on the 13th November! Links to register are below for anybody who's interested in coming along - even if you're from another university, you know you really want to come out and support me 😉

Such a great service for cancer care in the mid-west! Quality of life for cancer survivors is so important. Lymphedema reduced from 25% to 2% !

Updated treatment algorithms for breast cancer now include adjuvant ribociclib and inavolisib, along with trial names. Thrilled to see we're truly running out of space in HR+ disease—progress is here, with much more to come for all breast cancer subtypes #bcsm Dana-Farber’s Breast Oncology Center

I've been absolutely thrilled this year to take part first in DCU's Tell It Straight and last week in the national Three Minute Thesis final. It was such a joy from start to finish, and an honour to compete alongside INCREDIBLE researchers in such a wide range of areas 🧵1/